학술논문

Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
Document Type
Journal
Source
NEUROLOGY; APR 25 2023, 100 17, p4181 8p. Supplement: 2
Subject
Language
English
ISSN
1526632X